DarioHealth Corp. (Nasdaq: DRIO) (“Dario” or the “Company”), a leader in digital health solutions for chronic condition management, announces that its Board of Directors has initiated a comprehensive strategic review to maximize shareholder value following multiple unsolicited inbound strategic inquiries from interested parties. Dario’s Board of Directors has established a special committee (the “Special Committee”) of independent directors. The Special Committee will consider a full range of potential opportunities including a sale, merger, strategic business combination, or continued execution of the Company’s successful standalone strategy.
Read the full article: DarioHealth Announces Strategic Review Following Multiple Unsolicited Inbound Expressions of Interest //
Source: https://www.prnewswire.com/news-releases/dariohealth-announces-strategic-review-following-multiple-unsolicited-inbound-expressions-of-interest-302566366.html